Clinical Trials Related to Atopic Dermatitis

Related studies linked through entity extraction aliases.

Psychiatric Problems in Chronic Skin Diseases

Status: COMPLETED
Phase: N/A

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Status: COMPLETED
Phase: PHASE4

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

Status: COMPLETED
Phase: PHASE4

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Status: COMPLETED
Phase: PHASE4

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Status: TERMINATED
Phase: PHASE1/PHASE2

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis

Status: COMPLETED
Phase: PHASE1/PHASE2

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Status: TERMINATED
Phase: PHASE4

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Status: COMPLETED
Phase: PHASE4

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Status: COMPLETED
Phase: PHASE3

Quality of Life Study in Adults With Facial Eczema

Status: COMPLETED
Phase: PHASE4

Combination Therapy for Atopic Dermatitis

Status: COMPLETED
Phase: PHASE4

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

Status: COMPLETED
Phase: PHASE4

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Status: COMPLETED
Phase: N/A

Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

Status: COMPLETED
Phase: PHASE2

Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals

Status: COMPLETED
Phase: N/A